JP2011516610A5 - - Google Patents

Download PDF

Info

Publication number
JP2011516610A5
JP2011516610A5 JP2011505149A JP2011505149A JP2011516610A5 JP 2011516610 A5 JP2011516610 A5 JP 2011516610A5 JP 2011505149 A JP2011505149 A JP 2011505149A JP 2011505149 A JP2011505149 A JP 2011505149A JP 2011516610 A5 JP2011516610 A5 JP 2011516610A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
compound
group
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011505149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011516610A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/040567 external-priority patent/WO2009134616A2/en
Publication of JP2011516610A publication Critical patent/JP2011516610A/ja
Publication of JP2011516610A5 publication Critical patent/JP2011516610A5/ja
Pending legal-status Critical Current

Links

JP2011505149A 2008-04-15 2009-04-14 Ｃ型肝炎ウイルス複製の新規な阻害剤 Pending JP2011516610A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US4521908P 2008-04-15 2008-04-15
US4521408P 2008-04-15 2008-04-15
US61/045,214 2008-04-15
US61/045,219 2008-04-15
US10985608P 2008-10-30 2008-10-30
US61/109,856 2008-10-30
US11791608P 2008-11-25 2008-11-25
US61/117,916 2008-11-25
US14833709P 2009-01-29 2009-01-29
US61/148,337 2009-01-29
PCT/US2009/040567 WO2009134616A2 (en) 2008-04-15 2009-04-14 Novel inhibitors of hepatitis c virus replication

Publications (2)

Publication Number Publication Date
JP2011516610A JP2011516610A (ja) 2011-05-26
JP2011516610A5 true JP2011516610A5 (OSRAM) 2012-06-07

Family

ID=41078055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505149A Pending JP2011516610A (ja) 2008-04-15 2009-04-14 Ｃ型肝炎ウイルス複製の新規な阻害剤

Country Status (10)

Country Link
US (1) US20090257979A1 (OSRAM)
EP (1) EP2283002A2 (OSRAM)
JP (1) JP2011516610A (OSRAM)
KR (1) KR20110004439A (OSRAM)
CN (1) CN102026990A (OSRAM)
AU (1) AU2009241514A1 (OSRAM)
BR (1) BRPI0911259A2 (OSRAM)
CA (1) CA2720846A1 (OSRAM)
MX (1) MX2010011307A (OSRAM)
WO (1) WO2009134616A2 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007308141B2 (en) 2006-10-12 2013-08-29 Galera Labs, Llc Methods of treating oral mucositis
WO2011049987A2 (en) * 2009-10-20 2011-04-28 Eiger Biopharmaceuticals, Inc. Azaindazoles to treat flaviviridae virus infection
TW201121968A (en) * 2009-11-09 2011-07-01 Intermune Inc Novel inhibitors of hepatitis C virus replication
AU2012316397B2 (en) 2011-09-26 2016-07-21 Galera Labs, Llc Methods for treatment of diseases
CH707030B1 (de) 2011-10-21 2015-03-13 Abbvie Inc Kombinationsbehandlung von DAAs zur Verwendung in der Behandlung von HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
ES2529143B1 (es) 2011-10-21 2015-10-26 Abbvie Inc. Combinación de al menos dos agentes antivirales de acción directa, ribavirina pero no interferón para uso de tratamiento del vhc
WO2015018797A2 (en) * 2013-08-05 2015-02-12 Haplogen Gmbh Antiviral compounds
CN105991908B (zh) * 2015-03-16 2019-06-07 迈科威特株式会社 摄像机模块用滤光器转换装置及包含该模块的移动设备
HUE049926T2 (hu) 2015-08-11 2020-11-30 Galera Labs Llc Makrociklusos pentaazagyûrûkomplexek orális biológiai hozzáférhetõséggel
EP3448392A4 (en) 2016-04-28 2020-01-15 Emory University ALKYNOUS THERAPEUTIC NUCLEOTIDE AND NUCLEOSIDE COMPOSITIONS AND RELATED APPLICATIONS
KR20180132939A (ko) 2016-05-03 2018-12-12 갈레라 랩스, 엘엘씨 암 치료를 위한 조합 요법
EP3506907B1 (en) 2016-09-01 2023-06-07 Galera Labs, LLC Combination cancer therapy with a pentaaza macrocyclic ring complex and an ascorbate compound
IL269915B (en) 2017-04-13 2022-09-01 Galera Labs Llc Cancer immunotherapy combined with a macrocyclic ring pentase complex

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6025984A (ja) * 1983-07-22 1985-02-08 Tokyo Inst Of Technol ベンゾチアジアジン誘導体の製造方法
JPH0216448A (ja) * 1988-07-04 1990-01-19 Fuji Photo Film Co Ltd 化学物質の分配係数の推算処理方法
CN1158290C (zh) * 1996-01-17 2004-07-21 诺沃挪第克公司 稠合1,2,4-噻二嗪与稠合1,4-噻嗪衍生物、其制备方法及用途
US6242443B1 (en) * 1996-06-21 2001-06-05 Novo Nordisk Ais 1,2,4-benzothiadiazine derivatives, their preparation and use
US6156700A (en) * 1997-09-17 2000-12-05 American Cyanmid Company 3-(1,2-Benzisothiazol- and isoxazol-5-yl)-2,4(1H,3H)-pyrimidinedione or thione and 3-(1,2-benzisothiazol- and isoxazol-5-yl)-4(3H)-pyrimidinone or thione herbicidal agents
US6943159B1 (en) * 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
US7902203B2 (en) * 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US20040097492A1 (en) * 2002-11-01 2004-05-20 Pratt John K Anti-infective agents
US20050075331A1 (en) * 2003-10-06 2005-04-07 Pratt John K. Anti-infective agents
US20040162285A1 (en) * 2002-11-01 2004-08-19 Pratt John K. Anti-infective agents
DE60335564D1 (de) * 2002-11-01 2011-02-10 Abbott Lab Antiinfektiöse mittel
KR20050122220A (ko) * 2003-03-25 2005-12-28 다케다 샌디에고, 인코포레이티드 디펩티딜 펩티다제 억제제
US7378414B2 (en) * 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
DE602005015732D1 (de) * 2004-08-23 2009-09-10 Hoffmann La Roche Heterozyklische antivirale verbindungen
WO2006045096A2 (en) * 2004-10-20 2006-04-27 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
WO2006093801A1 (en) * 2005-02-25 2006-09-08 Abbott Laboratories Thiadiazine derivatives useful as anti-infective agents
JP2008540370A (ja) * 2005-05-04 2008-11-20 エフ．ホフマン−ラ ロシュ アーゲー ヘテロ環式抗ウイルス化合物
US7462611B2 (en) * 2006-06-22 2008-12-09 Anadys Pharmaceuticals, Inc. Pyrro[1,2-b]pyridazinone compounds
JP4199273B2 (ja) * 2006-08-29 2008-12-17 本田技研工業株式会社 車両状態推定装置
CL2007003587A1 (es) * 2006-12-12 2008-07-04 Anadys Pharmaceuticals Inc Compuestos derivados de pirimidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para tratar o prevenir la infeccion de la hepatitis c.
US20080188466A1 (en) * 2006-12-21 2008-08-07 Anadys Pharmaceuticals, Inc. Pyridazinone compounds
JP5236664B2 (ja) * 2007-02-01 2013-07-17 レスバーロジックス コーポレイション 心血管疾患を予防および治療するための化合物
US20080227774A1 (en) * 2007-03-15 2008-09-18 Frank Ruebsam 5,5-disubstituted-indolizinone compounds
US7834009B2 (en) * 2007-08-27 2010-11-16 Anadys Pharmaceuticals, Inc. 4-hydroxy-5,6-dihydro-1H-pyridin-2-one compounds
CN102316871B (zh) * 2008-06-10 2014-06-04 安那迪斯药品股份有限公司 [1，2，4]噻二嗪1，1-二氧化合物

Similar Documents

Publication Publication Date Title
JP2011516610A5 (OSRAM)
JP2011219498A5 (OSRAM)
JP2013523765A5 (OSRAM)
JP2013503846A5 (OSRAM)
EA200901241A1 (ru) Соединения для лечения гепатита с
EA201290053A1 (ru) Ингибиторы вирусов flaviviridae
JP2010524932A5 (OSRAM)
NO20082934L (no) Antivirale nukleotider
JP2012041349A5 (OSRAM)
JP2014500861A5 (OSRAM)
JP2013537203A5 (OSRAM)
WO2008085508A3 (en) Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
JP2017515901A5 (OSRAM)
JP2012519691A5 (OSRAM)
JP2014500265A5 (OSRAM)
EA025252B1 (ru) Способы и соединения для лечения вирусных инфекций paramyxoviridae
TR201815272T4 (tr) İnfluenza virüs replikasyonu inhibitörleri.
JP2011520906A5 (OSRAM)
WO2007095269A3 (en) Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection
EA200802346A1 (ru) Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с
MX2010002904A (es) N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
JP2008523082A5 (OSRAM)
TW200720285A (en) Nucleoside compounds for treating viral infections
MY157435A (en) Heterocyclic antiviral compounds
JP2018507261A5 (OSRAM)